Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERBITUX SOLN FOR INF /ML: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

Gender data not available for ERBITUX SOLN FOR INF /ML.

Age Information

The average age of patients reporting adverse events with ERBITUX SOLN FOR INF /ML is 66.5 years.

Geographic Distribution

The majority of adverse event reports for ERBITUX SOLN FOR INF /ML originate from DE.

Report Summary & Outcomes

55
Total Reports
55
As Primary/Secondary Suspect
18
Deaths Reported
24
Hospitalizations
11
Life-Threatening
6
Disabilities

Reporting Timeline

First adverse event report: 20120501. Most recent report: 20140611. View full timeline →

More About ERBITUX SOLN FOR INF /ML

ERBITUX SOLN FOR INF /ML Full Profile Reports by Year Drug Interactions